"We are very pleased and proud to be a sponsor of this important new conference," said Jeb Besser, CEO of Modular Medical. "The conference mission aligns closely with our corporate vision to ...

Altimmune has hired Greg Weaver as the clinical-stage biopharmaceutical company's new chief financial officer. Altimmune on Monday said Weaver most recently served as finance chief of Cognito ...

RadNet posted Q3 2024 revenue of $461.1 million, beating estimates. Digital Health revenue rose 34.3%, driving growth in AI ...

Chris Caldwell, President and CEO of Concentrix, to discuss AI's transformative impact on the customer experienceCompany to showcase leading-edge technologies at Stand 0404-16, FIL1 Pavilion 1 NEWARK ...

Thank you, Briana. Good afternoon, and welcome to Tempus’ third quarter 2024 conference call. This afternoon, Tempus released results for the quarter ending September 30, 2024. Joining me today from ...

Next June, Gartner will succeed Lanny McDonald as Hall of Fame chairman, the latter’s 10-year term coming to an end at that ...

Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine ...

Arbutus Biopharma Corporation (Nasdaq: ABUS) has released its third-quarter 2024 financial results, showcasing significant ...

Bill Presley, Vice-Chairman and COO of Aptiv PLCto become President and CEO, and Board Director, as of January 1, 2025Phil Eyler to Remain as an ...

Ricks is being recognized for his contributions to Indiana’s life sciences sector and his global impact on health care ...

Collegium Pharmaceutical ( (COLL)) has shared an announcement. Vikram Karnani has been appointed as the new CEO of Collegium Pharmaceutical, effective November 12, 2024, succeeding Michael Heffernan, ...

Collegium Pharmaceutical said it named Vikram Karnani as chief executive, effective Nov. 12. The specialty pharmaceutical company on Thursday said that Karnani, who will also be joining the board, ...